Pancreatic Cancer Treatment News

french drugmaker ipsen to buy assets from merrimack pharmaceuticals inc

French Drugmaker, Ipsen, to Buy Assets from Merrimack Pharmaceuticals Inc.

Medical Pavan Pandey - Jan 09, 2017

Ipsen SA said it would purchase some assets of US peer Merrimack Pharmaceuticals Inc., which includes the firm’s pancreatic cancer treatment  Onivyde , for up to $1 billion.

Total Records (1 )